- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05493436
The Influence of Obesity to Esophageal Reflux Severity Measured by pH-Metri Impedans on Gastroesophageal Reflux Disease Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Gastroesophageal reflux disease (GERD) prevalence is increasing worldwide. It is known that GERD correlates with obesity. In order to see further association between obesity and severity degree of esophageal reflux, GERD must be diagnosed with greater precision and accuracy. Therefore, study to see the impact of obesity in esophageal reflux severity measured by multicanal intraluminal impedance pH-meter (MII-pH) in GERD patient is compulsory.
The objective of this study is to explain the impact of obesity on severity of esophageal reflux in GERD patient measured by DeMeester score, hiatal hernia incidence, and the prolongation of acid exposure time in GERD patient.
This cross-sectional study recruited patients from Gastroenterology Clinic, Internal Medicine Department Cipto Mangunkusumo Hospital during May-August 2017. Patient with normal and obese body mass index (BMI) suspected having GERD were surveyed using GERDQ to diagnose GERD in these patients. Upper gastrointestinal endoscopy were performed to see hiatal hernia. All patients recruited underwent MII-pH examination to measure DeMeester score and acid exposure time. Results were analyzed using bivariat analysis.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
DKI Jakarta
-
Jakarta, DKI Jakarta, Indonesia
- RSCM
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- GERD patients diagnosed by GerdQ
- Adult patient age 18-60 years
- Patients with nutritional status based on normal BMI (18.5-24.9) and obesity (≥30)
- Willing to participate in research and sign informed consent
Exclusion Criteria:
- At the endoscopic examination found Barrett's esophagus, peptic ulcer, severe gastritis, severe NSAID gastropathy, hemorrhage (melenae), gastric cancer, esophageal cancer
- MII-pH check failed to install
- Patients are not cooperative
- Patients with acute psychiatric disorders
- Patients with severe heart trouble, persistent asthma patients, decompensated liver cirrhosis and chronic renal disease
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
normoweight
GERD patient with normoweight was evaluating by MII pH-meter
|
using multichannel impedance pH-meter
|
|
obesity
GERD patient with obesity was evaluating by MII pH-meter
|
using multichannel impedance pH-meter
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Composite pH score/DeMesster Score
Time Frame: January 2017 - October 2017
|
Participants underwent multichannel intraluminal impedance pH-meter (MII-pH) monitoring for quantification of the DeMeester score and acid exposure time
|
January 2017 - October 2017
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acid exposure time
Time Frame: January 2017 - October 2017
|
Percent of acid exposure time (AET) at pH < 4 for each study groups
|
January 2017 - October 2017
|
|
Incidence of Hiatal Hernia
Time Frame: January 2017 - October 2017
|
Incidence of hiatal hernia is measured for each group
|
January 2017 - October 2017
|
|
Incidence of Erosive Esophagitis
Time Frame: January 2017 - October 2017
|
Incidence of erosive esophagitis is measured for each group
|
January 2017 - October 2017
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IndonesiaSatu
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Disorder of Upper Esophageal Sphincter
-
University Hospital, Strasbourg, FranceUnknown
-
National Taiwan University HospitalNot yet recruitingUpper Esophageal Sphincter Relaxing Pressure
-
National Taiwan University HospitalNot yet recruitingThe Upper Esophageal Sphincter Contraction Strength
-
Region Örebro CountyCompletedLower Esophageal SphincterSweden
-
Austrian Society Of Surgical OncologyCompletedQuality of Life | Gastro Esophageal Reflux | Dysphagia | Electrical Stimulation of the Lower Esophageal SphincterAustria
-
Antalya Training and Research HospitalCompletedDisorder of Upper ExtremityTurkey
-
Antalya Training and Research HospitalCompletedDisorder of Upper ExtremityTurkey
-
Lawson Health Research InstituteThe Physicians' Services Incorporated FoundationCompletedDisorder of Upper ExtremityCanada
-
Peking University Third HospitalUnknown
-
Asian Institute of Gastroenterology, IndiaCompleted
Clinical Trials on MII pH-meter
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
Devicare S.L.Clever Instruments S.L.; Fundacio PuigvertUnknown
-
Boston Medical CenterPatient-Centered Outcomes Research Institute; Boston Healthcare for the Homeless... and other collaboratorsRecruitingHypertension | Hypertension ComplicatedUnited States
-
The University of Texas Health Science Center,...Smart Meter CorporationRecruitingType2 Diabetes | Gestational Diabetes | Pregnancy in DiabeticUnited States
-
University of New MexicoNational Institute on Drug Abuse (NIDA)RecruitingSubstance-Related Disorders | Treatment AdherenceUnited States
-
Connecticut Children's Medical CenterGlobal Center for Glycogen Storage Disease held at the Jewish Community FoundationRecruiting
-
Holland Bloorview Kids Rehabilitation HospitalCompletedAutism Spectrum DisorderCanada
-
University of AlbertaCanadian VIGOUR CentreCompleted
-
HopeLab FoundationStanford University; West Virginia University; Santech, IncCompletedHealth Behavior | Motivation | Adolescent BehaviorUnited States